LivaNova (LIVN) Enterprise Value Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.72% |
| Dec 31, 2025 | -48.20% |
| Jun 30, 2025 | -80.70% |
| Mar 31, 2025 | -109.71% |
| Dec 31, 2024 | -40.61% |
| Sep 30, 2024 | -17.08% |
| Jun 30, 2024 | -47.54% |
| Mar 31, 2024 | -3.67% |
| Dec 31, 2023 | 14.61% |
| Sep 30, 2023 | -8.28% |
| Jun 30, 2023 | 36.63% |
| Mar 31, 2023 | 7.71% |
| Dec 31, 2022 | -13.52% |
| Sep 30, 2022 | 0.67% |
| Jun 30, 2022 | 19.00% |
| Mar 31, 2022 | -45.72% |
| Dec 31, 2021 | -23.44% |
| Sep 30, 2021 | -21.93% |
| Jun 30, 2021 | -86.95% |
| Mar 31, 2021 | -100.71% |
| Dec 31, 2020 | -316.91% |
| Sep 30, 2020 | -202.49% |
| Jun 30, 2020 | -422.45% |
| Mar 31, 2020 | -147.80% |
| Dec 31, 2019 | -29.52% |
| Sep 30, 2019 | 5.80% |
| Jun 30, 2019 | 6.06% |
| Mar 31, 2019 | 21.84% |
| Dec 31, 2018 | 49.58% |
| Sep 30, 2018 | -22.70% |
| Jun 30, 2018 | -10.99% |
| Mar 31, 2018 | -3.58% |
| Dec 31, 2017 | -135.28% |
| Sep 30, 2017 | -2.40% |
| Jun 30, 2017 | 39.78% |
| Mar 31, 2017 | 33.60% |
| Dec 31, 2016 | 66.73% |
| Oct 18, 2015 | -68.41% |
| Apr 24, 2015 | -21.76% |